Phosphorylation of p38 by GRK2 at the Docking Groove Unveils a Novel Mechanism for Inactivating p38MAPK
暂无分享,去创建一个
P. Crespo | C. Murga | V. Sanz-Moreno | F. Mayor | Sandra Peregrín | M. Jurado-Pueyo | P. M. Campos | A. Ruiz-Gómez | P. Campos | María Jurado-Pueyo
[1] J. Redondo,et al. Systematic characterization of phosphorylation sites in NFATc2 by linear ion trap mass spectrometry , 2006, Proteomics.
[2] R. Perdrisot,et al. Pathophysiological roles of G-protein-coupled receptor kinases. , 2005, Cellular signalling.
[3] J. Vázquez,et al. S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[4] M. Caron,et al. G Protein-Coupled Receptor Kinase 2 in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis , 2005, The Journal of Immunology.
[5] Yibin Wang,et al. Stress-activated MAP kinases in cardiac remodeling and heart failure; new insights from transgenic studies. , 2004, Trends in cardiovascular medicine.
[6] C. Ribas,et al. Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. , 2003, Cellular signalling.
[7] J. Boehm,et al. p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.
[8] P. Penela,et al. MAPK-dependent Degradation of G Protein-coupled Receptor Kinase 2* , 2003, Journal of Biological Chemistry.
[9] Tatsuya Haga,et al. Identification of sites of phosphorylation by G-protein-coupled receptor kinase 2 in beta-tubulin. , 2003, European journal of biochemistry.
[10] C. Notcovich,et al. Reduction of G protein-coupled receptor kinase 2 expression in U-937 cells attenuates H2 histamine receptor desensitization and induces cell maturation. , 2002, Molecular pharmacology.
[11] C. Slaughter,et al. Binding of JNK/SAPK to MEKK1 Is Regulated by Phosphorylation* , 2002, The Journal of Biological Chemistry.
[12] Radha Akella,et al. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.
[13] J. Port,et al. Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. , 2002, Journal of cardiac failure.
[14] M. Cobb,et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.
[15] M. Schedlowski,et al. Adjuvant Arthritis Induces Down-Regulation of G Protein-Coupled Receptor Kinases in the Immune System1 , 2001, The Journal of Immunology.
[16] M. Lohse,et al. Phosphorylation of Phosducin and Phosducin-like Protein by G Protein-coupled Receptor Kinase 2* , 2000, The Journal of Biological Chemistry.
[17] A. Sharrocks,et al. Docking domains and substrate-specificity determination for MAP kinases. , 2000, Trends in biochemical sciences.
[18] J. Benovic,et al. Synucleins Are a Novel Class of Substrates for G Protein-coupled Receptor Kinases* , 2000, The Journal of Biological Chemistry.
[19] A. Porras,et al. p38 MAP kinases: beyond the stress response. , 2000, Trends in biochemical sciences.
[20] F. Mayor,et al. Agonist-dependent modulation of G protein-coupled receptor kinase 2 by mitogen-activated protein kinases. , 2000, Molecular pharmacology.
[21] Carmen Blanco-Aparicio,et al. A Novel Regulatory Mechanism of Map Kinases Activation and Nuclear Translocation Mediated by Pka and the Ptp-Sl Tyrosine Phosphatase , 1999, The Journal of cell biology.
[22] J. Engelman,et al. Constitutively Active Mitogen-activated Protein Kinase Kinase 6 (MKK6) or Salicylate Induces Spontaneous 3T3-L1 Adipogenesis* , 1999, The Journal of Biological Chemistry.
[23] Julie A. Pitcher,et al. Feedback Inhibition of G Protein-coupled Receptor Kinase 2 (GRK2) Activity by Extracellular Signal-regulated Kinases* , 1999, The Journal of Biological Chemistry.
[24] J. Bijlsma,et al. Decreased expression and activity of G‐protein‐coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] J. Engelman,et al. Specific Inhibitors of p38 Mitogen-activated Protein Kinase Block 3T3-L1 Adipogenesis* , 1998, The Journal of Biological Chemistry.
[26] M. Caron,et al. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] I. Garcı́a-Higuera,et al. High affinity binding of beta-adrenergic receptor kinase to microsomal membranes. Modulation of the activity of bound kinase by heterotrimeric G protein activation. , 1996, The Journal of biological chemistry.
[28] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[29] M. Caron,et al. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[30] H. Green,et al. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion , 1975, Cell.
[31] Antonio S. Tutor,et al. Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease. , 2006, Cardiovascular research.
[32] Jiahuai Han,et al. Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.